News about Global Pharma

Stevanato Group Inaugurates New Plant in Cisterna di Latina

Stevanato Group Inaugurates New Plant in Cisterna di Latina

Stevanato Group has recently launched its Cisterna di Latina plant.

Global Pharma | 31/05/2024 | By Aishwarya 721

Sanofi Announces Complete Acquisition of Inhibrx

Sanofi Announces Complete Acquisition of Inhibrx

Sanofi has recently announced the complete acquisition of Inhibrx, Inc.

Global Pharma | 31/05/2024 | By Aishwarya 249

Merck Signs MoU with KAIST to Boost Scientific Research

Merck Signs MoU with KAIST to Boost Scientific Research

Merck has signed a non-binding Memorandum of Understanding (MoU) with the Korea Advanced Institute of Science and Technology (KAIST).

Global Pharma | 31/05/2024 | By Aishwarya 354

PharmaLytica 2024 Commences Successfully in Hyderabad

PharmaLytica 2024 Commences Successfully in Hyderabad

Informa Markets India has announced the successful commencement of the 10th edition of PharmaLytica 2024 at HITEX, Hyderabad.

Global Pharma | 31/05/2024 | By Aishwarya 984

Nxera Pharma to Receive USD 4.6 Million from Centessa

Nxera Pharma to Receive USD 4.6 Million from Centessa

Nxera Pharma has been expecting to receive USD 4.6 million in milestone payments from Centessa Pharmaceuticals under a license agreement regarding Nxera technology used to help design Centessa’s novel orexin receptor 2 (OX2R) agonist, ORX750.

Global Pharma | 30/05/2024 | By Aishwarya 523

H.E.L Group Expands its Sales Newtowk with Addition of Two Specialist Distributors

H.E.L Group Expands its Sales Newtowk with Addition of Two Specialist Distributors

H.E.L Group (H.E.L) has expanded its global sales network with the appointment of two distributors: Paralab and ProAnalytics.

Global Pharma | 30/05/2024 | By Aishwarya 703

Merck Announces Acquisition of EyeBio

Merck Announces Acquisition of EyeBio

Merck has signed a definitive agreement under which Merck, through a subsidiary, will acquire EyeBio.

Global Pharma | 30/05/2024 | By Aishwarya 623

HanAll Biopharma and Turn Bio to Develop Novel Treatments for Eye and Ear Diseases

HanAll Biopharma and Turn Bio to Develop Novel Treatments for Eye and Ear Diseases

HanAll Biopharma Co., Ltd. has signed an exclusive licensing deal with Turn Biotechnologies, Inc., a pre-clinical stage biopharmaceutical company focused on cellular repair through epigenetic reprogramming.

Global Pharma | 29/05/2024 | By Aishwarya 2558

Reddy Pharma Iberia and Theranica Launch Nerivio in Spain

Reddy Pharma Iberia and Theranica Launch Nerivio in Spain

Dr. Reddy's Laboratories Ltd. and its subsidiaries have introduced Nerivio in Spain through its step-down subsidiary, Reddy Pharma Iberia S.A.

Global Pharma | 29/05/2024 | By Aishwarya 1093

Gerresheimer Expands Capacities for Medical Systems in USA

Gerresheimer Expands Capacities for Medical Systems in USA

Gerresheimer is significantly expanding its production capacities for medical systems such as inhalers and autoinjectors in the United States.

Global Pharma | 28/05/2024 | By Manvi 376

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members